Tolinapant

Recurrent Primary Peritoneal Adenocarcinoma

National Cancer Institute (NCI)Phase 1/2

—

Rating in progress

Tolinapant in Recurrent Primary Peritoneal Adenocarcinoma is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active